BIOSERGEN’S OFFERING IS FULLY SUBSCRIBED
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.Stockholm, Sweden, June 8, 2021: Biosergen AB today announces that the Unit offering of SEK 50 million (the “Offering”) was fully subscribed and that, subject to final approval, the Company will be listed on Nasdaq First North Growth